Avidity Biosciences is an American company majoring in biotech based on the discovery of pioneering medicines through partnering with large pharmaceutical companies.
Avidity cares for the production of a new class of precision medicines – Antibody-SIRNA Conjugates (ASC™) – which combine the strengths of monoclonal antibodies and SIRNA-based therapeutics. The company can generate big revenues for the use of biotech in similar ventures has recently yielded huge profits.
Avidity investors are among the most well-known CV investors in the sector of life sciences and biotech, and this is an added value for the company.
for more information please visit the company website at http://www.aviditybiosciences.com